Bibliography

  1. F. B. Peairs, “Bt Corn: Health and the Environment,” Production, no. 0.707 (Colorado State University Extension, August 2010). Alejandro E. Segarra and Jean M. Rawson, “StarLink Corn Controversy: Background,” CRS Report for Congress, updated January 10, 2001.

  2. Alejandro E. Segarra and Jean M. Rawson, “StarLink Corn Controversy: Background,” CRS Report for Congress, updated January 10, 2001.

  3. Mark K. Sears, Richard L. Hellmich, Diane E. Stanley-Horn, Karen S. Oberhauser, John M. Pleasants, Heather R. Mattila, Blair D. Siegfried, and Galen P. Dively, “Impact of Bt corn pollen on monarch butterfly populations: A risk assessment,” Proceedings of the National Academy of Sciences, vol. 98, no. 21 (October 9, 2001), pp. 11937–11942.

  4. David Liénard, Christophe Sourrouille, Véronique Gomord, and Loic Faye, “Pharming and transgenic plants,” Biotechnology Annual Review, vol. 13 (2007), pp. 115-147.

  5. Abdoreza Davoodi-Semiromi, Natapalli Samson, and Henry Daniell, “The green vaccine: A global strategy to combat infectious and autoimmune diseases,” Human Vaccines, vol. 5, no. 7 (July 2009), pp. 448-493.

  6. Center for Science in the Public Interest, “The Future of Pharming: Can It Be Done Safely?” Roundtable Discussion, December 17, 2002. Natasha Gilbert, “Fees delayed pharmed drug,” Nature, vol. 458, no. 951 (2009). National Research Council, Animal Biotechnology: Science Based Concerns (Washington, DC: National Academies Press, 2002), p. 12.

  7. Union of Concerned Scientists, “Position Paper: Pharmaceutical and Industrial Crops,” (October 2006), pp 1-23

  8. Pal, K. K. and B. McSpadden Gardener, 2006. “Biological Control of Plant Pathogens.” The Plant Health Instructor, 2006, pp1-25.

  9. Greg Jaffe, “Questions About Genetically Engineered Animals,” Miami Herald, October 23

  10. Gregory Jaffe, “Regulatory slowdown on GM crop decisions,” Nature Biotechnology, vol. 24, no. 7 (July 2006), pp. 7480749.

  11. Federation of Animal Science Societies, “Guide for the Care and Use of Agricultural Animals in Research and Teaching,” (January 2010), pp1-160

  12. Center for Science in the Public Interest, “How Should the Next Administration Address Genetically Engineered Food Animals?” Greg Jaffe, “Questions About Genetically Engineered Animals,” Miami Herald, October 23, 2008.

  13. ActionBioscience.org, “Transgenic Animals: Their Benefits to Human Welfare.”

  14. University of Guelph, EnviropigTM http://www.uoguelph.ca/enviropig/technology.shtml

  15. Gregory Jaffe, “Genetically Engineered Salmon – Healthy for You, But is it Healthy for the Earth?” FDLI Update (Washington, DC: Food and Drug Law Institute), November/December 2010, p. 34.

  16. Yann Echelard, Carol A. Ziomek, and Harry M. Meade, “Production of recombinant therapeutic proteins in the milk of transgenic animals,” BioPharm International.com, August 1, 2008.

  17. Echelard, Ziomek, and Meade, “Production of Recombinant Therapeutic Proteins.”, http://biopharminternational.findpharma.com/biopharm/Article/Production-of-Recombinant-Therapeutic-Proteins-in-/ArticleStandard/Article/detail/362005

  18. Lois Rogers, “Hop over here, Flopsy Bunny, stroke victims need your milk,” London Sunday Times, January 17, 2010. Heiner Niemann and Wilfried A. Kues, “Transgenic farm animals: an update,” Reproduction, Fertility and Development, vol. 19, no. 6 (August 2, 2007), pp. 762-770. Jim Kling, “First US approval for a transgenic animal drug,” Nature Biotechnology, vol. 27 (2009), pp. 302-304

  19. ActionBioscience.org, “Transgenic Animals”; David Gillespie, “Pharming for Farmaceuticals,” Department of Genetics, University of Utah, http://www.learn.genetics.utah.edu

  20. Emanuele Cozzi and David J.G. White, “The generation of transgenic pigs as potential organ donors for humans,” Nature Medicine, vol. 1, no. 9 (September 1995), pp. 964-966.

  21. Robin A Weiss, “The discovery of endogenous retroviruses”, Retrovirology (October 2006) http://www.retrovirology.com/content/3/1/67